Tickers — E

79 tickers
Ranks this page's recent reports by score.
Eastman Chemical Company
EMN·Materials
B ★★★Hold
Current$66.53
Target$76.80
Return+15.4%
Nov 2, 2026

Eastman's discounted specialty-materials portfolio and circular-recycling growth opportunity offer recovery potential, but elevated leverage, uneven cash conversion, and cyclical industrial demand constrain the near-term investment case.

Score
74
Enel Chile S.A.
ENIC·Utilities
A ★★★★Buy
Current$4.13
Target$4.60
Return+11.4%
Nov 2, 2026

Enel Chile offers substantial electricity infrastructure, positive cash flow, and an attractive historical valuation discount, although hydrological volatility, regulatory exposure, and non-recurring earnings limit confidence in sustained profit growth.

Score
76
Etsy, Inc.
ETSY·Consumer Discretionary
B ★★★Hold
Current$88.96
Target$96.00
Return+7.9%
Nov 2, 2026

Etsy's specialized marketplace, improving buyer engagement, and aggressive buybacks support per-share cash-flow growth, but intense competition and uncertain long-term purchasing frequency limit conviction in sustained expansion.

Score
73
Element Solutions Inc
ESI·Materials
B ★★★Hold
Current$34.27
Target$42.00
Return+22.6%
Nov 1, 2026

Element Solutions benefits from rising electronics materials complexity, durable qualification barriers and acquisition-driven expansion, but elevated leverage, uneven cash conversion and a historical valuation premium limit the margin of safety.

Score
69
Erie Indemnity Company
ERIE·Financials
A ★★★★Buy
Current$261.39
Target$283.20
Return+8.3%
Nov 1, 2026

Erie Indemnity offers a durable, cash-generative insurance management franchise at a valuation below historical norms, although concentrated governance, CEO succession, and subdued earnings growth limit its near-term upside.

Score
83
Eagle Materials Inc.
EXP·Materials
B ★★★Hold
Current$183.64
Target$202.50
Return+10.3%
Nov 1, 2026

Eagle Materials combines durable regional cement and wallboard advantages with substantial shareholder buybacks and modernization upside, but cyclical construction demand and elevated capital spending threaten near-term margins and free cash flow.

Score
72
Exelixis, Inc.
EXEL·Healthcare
B ★★★Hold
Current$69.39
Target$65.45
Return-5.7%
Nov 1, 2026

Exelixis combines exceptional oncology cash generation and substantial buybacks with a promising second drug franchise, but CABOMETYX concentration and a historically elevated valuation limit the margin for regulatory disappointment.

Score
70
Exponent, Inc.
EXPO·Industrials
A ★★★★Buy
Current$80.26
Target$87.29
Return+8.8%
Nov 1, 2026

Exponent combines specialist scientific expertise, exceptional capital returns, and accelerating consulting demand, but its premium earnings multiple and project-based revenue create sensitivity to growth disappointments.

Score
79
EPAM Systems, Inc.
EPAM·Technology
A ★★★★Buy
Current$140.51
Target$154.22
Return+9.8%
Nov 1, 2026

EPAM offers a profitable, cash-rich engineering franchise with potential AI-driven growth and margin recovery at historically modest valuation multiples, although weak organic growth and uncertain AI service economics remain important risks.

Score
78
Expedia Group, Inc.
EXPE·Consumer Discretionary
A ★★★★Buy
Current$285.93
Target$315.00
Return+10.2%
Nov 1, 2026

Expedia combines a profitable global travel marketplace with fast-growing B2B distribution and attractive forward earnings valuation, although search competition, travel cyclicality, and working-capital volatility could limit returns.

Score
81
Entegris, Inc.
ENTG·Technology
B ★★★Hold
Current$154.39
Target$162.00
Return+4.9%
Nov 1, 2026

Entegris benefits from rising semiconductor materials intensity, strong process-level switching costs, and improving cash generation, but elevated valuation and acquisition-related leverage limit the margin of safety.

Score
66